Chuanxin Biomedical (Suzhou) Co., Ltd. announced that it has received CNY 150,000,000 in a round of funding on June 29, 2023. The transaction included participation from new investor Changchun BCHT Biotechnology Co.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.49 CNY | -2.88% | +3.63% | -26.13% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.13% | 2.39B | |
+7.91% | 72.94B | |
+12.64% | 9.06B | |
-10.56% | 5.07B | |
+58.79% | 4.78B | |
+4.07% | 3.9B | |
-16.90% | 2.56B | |
+20.84% | 2.42B | |
+19.31% | 2.18B | |
+0.03% | 1.65B |
- Stock Market
- Equities
- 688276 Stock
- News Changchun BCHT Biotechnology Co.
- Chuanxin Biomedical Co., Ltd. announced that it has received CNY 150 million in funding from Changchun BCHT Biotechnology Co.